Global Non-Invasive Cancer Diagnostics Market Insights, Forecast to 2027

Report Description


The Global Non-Invasive Cancer Diagnostics Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Non-Invasive Cancer Diagnostics Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Non-Invasive Cancer Diagnostics Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Non-Invasive Cancer Diagnostics Market product affairs. The report is at risk of project regarding this Non-Invasive Cancer Diagnostics Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Gen-Probe Inc
  • Digene Corporation
  • Quest Diagnostics Inc
  • Cancer
  • Genetics Inc
  • BIOVIEW Inc
  • AVIVA Biosciences Corporation
  • Laboratory Corporation of America Holdings (LabCorp)
  • A&G Pharmaceutical
  • Affymetrix Inc
  • Precision Therapeutics

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Non-Invasive Cancer Diagnostics related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Non-Invasive Cancer Diagnostics Market

Non-Invasive Cancer Diagnostics Market

Report Highlights:


The Non-Invasive Cancer Diagnostics Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Non-Invasive Cancer Diagnostics Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Non-Invasive Cancer Diagnostics Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Non-Invasive Cancer Diagnostics Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Non-Invasive Cancer Diagnostics marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Non-Invasive Cancer Diagnostics market using a bottom-up approach, wherein manufacturers value data for different type (CTCs, CTNAS, Exosomes), of Non-Invasive Cancer Diagnostics market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Non-Invasive Cancer Diagnostics Market

Non-Invasive Cancer Diagnostics Market

Key Target Audience:


  • Non-Invasive Cancer Diagnostics market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Non-Invasive Cancer Diagnostics market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Non-Invasive Cancer Diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Non-Invasive Cancer Diagnostics market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • CTCs
  • CTNAS
  • Exosomes

By end-user also classify into, the Global Non-Invasive Cancer Diagnostics market:


Global Non-Invasive Cancer Diagnostics market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Blood
  • Urine
  • Saliva

Highlights of this 2021-2027 Non-Invasive Cancer Diagnostics Market Report:

  • Market dynamics, Non-Invasive Cancer Diagnostics economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Non-Invasive Cancer Diagnostics industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Non-Invasive Cancer Diagnostics Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Non-Invasive Cancer Diagnostics businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Non-Invasive Cancer Diagnostics market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

Table of Contents

1 Study Coverage
1.1 Non-Invasive Cancer Diagnostics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Product
1.4.2 CTCs
1.4.3 CTNAS
1.4.4 Exosomes
1.5 Market by End User
1.5.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by End User
1.5.2 Blood
1.5.3 Urine
1.5.4 Saliva
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Non-Invasive Cancer Diagnostics Market Size
2.1.1 Global Non-Invasive Cancer Diagnostics Revenue 2016-2027
2.1.2 Global Non-Invasive Cancer Diagnostics Sales 2016-2027
2.2 Non-Invasive Cancer Diagnostics Growth Rate by Regions
2.2.1 Global Non-Invasive Cancer Diagnostics Sales by Regions
2.2.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.2 Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers
3.1.3 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Non-Invasive Cancer Diagnostics Revenue by Manufacturers
3.2.1 Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2016-2021)
3.2.2 Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2016-2021)
3.3 Non-Invasive Cancer Diagnostics Price by Manufacturers
3.4 Non-Invasive Cancer Diagnostics Manufacturing Base Distribution, Product Types
3.4.1 Non-Invasive Cancer Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non-Invasive Cancer Diagnostics Product Type
3.4.3 Date of International Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Non-Invasive Cancer Diagnostics Sales by Product
4.2 Global Non-Invasive Cancer Diagnostics Revenue by Product
4.3 Non-Invasive Cancer Diagnostics Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Non-Invasive Cancer Diagnostics Breakdown Data by End User

6 North America
6.1 North America Non-Invasive Cancer Diagnostics by Countries
6.1.1 North America Non-Invasive Cancer Diagnostics Sales by Countries
6.1.2 North America Non-Invasive Cancer Diagnostics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Non-Invasive Cancer Diagnostics by Product
6.3 North America Non-Invasive Cancer Diagnostics by End User

7 Europe
7.1 Europe Non-Invasive Cancer Diagnostics by Countries
7.1.1 Europe Non-Invasive Cancer Diagnostics Sales by Countries
7.1.2 Europe Non-Invasive Cancer Diagnostics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Non-Invasive Cancer Diagnostics by Product
7.3 Europe Non-Invasive Cancer Diagnostics by End User

8 Asia Pacific
8.1 Asia Pacific Non-Invasive Cancer Diagnostics by Countries
8.1.1 Asia Pacific Non-Invasive Cancer Diagnostics Sales by Countries
8.1.2 Asia Pacific Non-Invasive Cancer Diagnostics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Non-Invasive Cancer Diagnostics by Product
8.3 Asia Pacific Non-Invasive Cancer Diagnostics by End User

9 Central & South America
9.1 Central & South America Non-Invasive Cancer Diagnostics by Countries
9.1.1 Central & South America Non-Invasive Cancer Diagnostics Sales by Countries
9.1.2 Central & South America Non-Invasive Cancer Diagnostics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Non-Invasive Cancer Diagnostics by Product
9.3 Central & South America Non-Invasive Cancer Diagnostics by End User

10 Middle East and Africa
10.1 Middle East and Africa Non-Invasive Cancer Diagnostics by Countries
10.1.1 Middle East and Africa Non-Invasive Cancer Diagnostics Sales by Countries
10.1.2 Middle East and Africa Non-Invasive Cancer Diagnostics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Non-Invasive Cancer Diagnostics by Product
10.3 Middle East and Africa Non-Invasive Cancer Diagnostics by End User

11 Company Profiles
11.1 Gen-Probe Inc
11.1.1 Gen-Probe Inc Company Details
11.1.2 Company Business Overview
11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.1.4 Gen-Probe Inc Non-Invasive Cancer Diagnostics Products Offered
11.1.5 Gen-Probe Inc Recent Development
11.2 Digene Corporation
11.2.1 Digene Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.2.4 Digene Corporation Non-Invasive Cancer Diagnostics Products Offered
11.2.5 Digene Corporation Recent Development
11.3 Quest Diagnostics Inc
11.3.1 Quest Diagnostics Inc Company Details
11.3.2 Company Business Overview
11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.3.4 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Products Offered
11.3.5 Quest Diagnostics Inc Recent Development
11.4 Cancer, Genetics Inc
11.4.1 Cancer, Genetics Inc Company Details
11.4.2 Company Business Overview
11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.4.4 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Products Offered
11.4.5 Cancer, Genetics Inc Recent Development
11.5 BIOVIEW Inc
11.5.1 BIOVIEW Inc Company Details
11.5.2 Company Business Overview
11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.5.4 BIOVIEW Inc Non-Invasive Cancer Diagnostics Products Offered
11.5.5 BIOVIEW Inc Recent Development
11.6 AVIVA Biosciences Corporation
11.6.1 AVIVA Biosciences Corporation Company Details
11.6.2 Company Business Overview
11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.6.4 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Products Offered
11.6.5 AVIVA Biosciences Corporation Recent Development
11.7 Laboratory Corporation of America Holdings (LabCorp)
11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
11.7.2 Company Business Overview
11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.7.4 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Products Offered
11.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
11.8 A&G Pharmaceutical
11.8.1 A&G Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.8.4 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Products Offered
11.8.5 A&G Pharmaceutical Recent Development
11.9 Affymetrix Inc
11.9.1 Affymetrix Inc Company Details
11.9.2 Company Business Overview
11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.9.4 Affymetrix Inc Non-Invasive Cancer Diagnostics Products Offered
11.9.5 Affymetrix Inc Recent Development
11.10 Precision Therapeutics
11.10.1 Precision Therapeutics Company Details
11.10.2 Company Business Overview
11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.10.4 Precision Therapeutics Non-Invasive Cancer Diagnostics Products Offered
11.10.5 Precision Therapeutics Recent Development

12 Future Forecast
12.1 Non-Invasive Cancer Diagnostics Market Forecast by Regions
12.1.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2021-2027
12.1.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2021-2027
12.2 Non-Invasive Cancer Diagnostics Market Forecast by Product
12.2.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Product 2021-2027
12.2.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Product 2021-2027
12.3 Non-Invasive Cancer Diagnostics Market Forecast by End User
12.4 North America Non-Invasive Cancer Diagnostics Forecast
12.5 Europe Non-Invasive Cancer Diagnostics Forecast
12.6 Asia Pacific Non-Invasive Cancer Diagnostics Forecast
12.7 Central & South America Non-Invasive Cancer Diagnostics Forecast
12.8 Middle East and Africa Non-Invasive Cancer Diagnostics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non-Invasive Cancer Diagnostics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Non-Invasive Cancer Diagnostics Product Picture
Table Non-Invasive Cancer Diagnostics Market Segments
Table Key Manufacturers Non-Invasive Cancer Diagnostics Covered
Table Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Product 2021-2027 (K Units) & (Million US$)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Product 2016-2027
Figure CTCs Product Picture
Table Major Manufacturers of CTCs
Figure CTNAS Product Picture
Table Major Manufacturers of CTNAS
Figure Exosomes Product Picture
Table Major Manufacturers of Exosomes
Table Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by End User 2021-2027 (K Units)
Figure Blood
Figure Urine
Figure Saliva
Figure Non-Invasive Cancer Diagnostics Report Years Considered
Figure Global Non-Invasive Cancer Diagnostics Market Size 2016-2027 (Million US$)
Figure Global Non-Invasive Cancer Diagnostics Sales 2016-2027 (K Units)
Table Global Non-Invasive Cancer Diagnostics Market Size by Regions 2016-2021 (K Units) & (Million US$)
Table Global Non-Invasive Cancer Diagnostics Sales by Regions 2016-2021 (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions 2016-2021
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions 2016-2021
Figure 2020 Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions
Table Global Non-Invasive Cancer Diagnostics Revenue by Regions 2016-2021 (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions 2016-2021
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions 2016-2021
Figure 2020 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions
Table Global Non-Invasive Cancer Diagnostics Sales by Manufacturers (2016-2021) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by Manufacturers (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Sales Share by Manufacturers in 2020
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2016-2021) (Million USD)
Table Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2016-2021)
Figure Non-Invasive Cancer Diagnostics Value Share by Manufacturers in 2020
Table Key Manufacturers Non-Invasive Cancer Diagnostics Price (2016-2021) (USD/Unit)
Table Non-Invasive Cancer Diagnostics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Non-Invasive Cancer Diagnostics Product Type
Table Date of International Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Non-Invasive Cancer Diagnostics Sales by Product (2016-2021) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by Product (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Product (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Product in 2020
Table Global Non-Invasive Cancer Diagnostics Revenue by Product (2016-2021) (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Share by Product (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Product (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Product in 2020
Table Non-Invasive Cancer Diagnostics Price by Product 2016-2021 (USD/Unit)
Table Global Non-Invasive Cancer Diagnostics Sales by End User (2016-2021) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by End User (2016-2021)
Figure Global Sales Non-Invasive Cancer Diagnostics Market Share by End User (2016-2021)
Figure Global Sales Non-Invasive Cancer Diagnostics Market Share by End User in 2020
Figure North America Non-Invasive Cancer Diagnostics Sales Growth Rate 2016-2021 (K Units)
Figure North America Non-Invasive Cancer Diagnostics Revenue Growth Rate 2016-2021 (Million US$)
Table North America Non-Invasive Cancer Diagnostics Sales by Countries (2016-2021) (K Units)
Table North America Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2016-2021)
Figure 2020 North America Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table North America Non-Invasive Cancer Diagnostics Revenue by Countries (2016-2021) (Million US$)
Table North America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2016-2021)
Figure 2020 North America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure United States Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure United States Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (K Units)
Figure Canada Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Canada Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Mexico Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Mexico Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Table North America Non-Invasive Cancer Diagnostics Sales by Product (2016-2021) (K Units)
Table North America Non-Invasive Cancer Diagnostics Sales Market Share by Product (2016-2021)
Figure 2020 North America Non-Invasive Cancer Diagnostics Market Share by Product
Table North America Non-Invasive Cancer Diagnostics Sales by End User (2016-2021) (K Units)
Table North America Non-Invasive Cancer Diagnostics Sales Market Share by End User (2016-2021)
Figure 2020 North America Non-Invasive Cancer Diagnostics Market Share by End User
Figure Europe Non-Invasive Cancer Diagnostics Sales Growth Rate 2016-2021 (K Units)
Figure Europe Non-Invasive Cancer Diagnostics Revenue Growth Rate 2016-2021 (Million US$)
Table Europe Non-Invasive Cancer Diagnostics Sales by Countries (2016-2021) (K Units)
Table Europe Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2016-2021)
Figure 2020 Europe Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table Europe Non-Invasive Cancer Diagnostics Revenue by Countries (2016-2021) (Million US$)
Table Europe Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2016-2021)
Figure 2020 Europe Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure Germany Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Germany Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure France Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure France Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure UK Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure UK Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Italy Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Italy Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Russia Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Russia Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Table Europe Non-Invasive Cancer Diagnostics Sales by Product (2016-2021) (K Units)
Table Europe Non-Invasive Cancer Diagnostics Sales Market Share by Product (2016-2021)
Figure 2020 Europe Non-Invasive Cancer Diagnostics Market Share by Product
Table Europe Non-Invasive Cancer Diagnostics Sales by End User (2016-2021) (K Units)
Table Europe Non-Invasive Cancer Diagnostics Sales Market Share by End User (2016-2021)
Figure 2020 Europe Non-Invasive Cancer Diagnostics Market Share by End User
Figure Asia Pacific Non-Invasive Cancer Diagnostics Sales Growth Rate 2016-2021 (K Units)
Figure Asia Pacific Non-Invasive Cancer Diagnostics Revenue Growth Rate 2016-2021 (Million US$)
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales by Countries (2016-2021) (K Units)
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2016-2021)
Figure 2020 Asia Pacific Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table Asia Pacific Non-Invasive Cancer Diagnostics Revenue by Countries (2016-2021) (Million US$)
Table Asia Pacific Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2016-2021)
Figure 2020 Asia Pacific Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure China Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure China Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Japan Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Japan Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Korea Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Korea Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure India Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure India Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Australia Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)

Non-Invasive Cancer Diagnostics Market Segments


Non-Invasive Cancer Diagnostics Product Type Outlook (Revenue, USD Million, 2021 2027)


  • CTCs
  • CTNAS
  • Exosomes

Non-Invasive Cancer Diagnostics Application Outlook (Revenue, USD Million, 2021 2027)


  • Blood
  • Urine
  • Saliva

Non-Invasive Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

  • Europe
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

  • Asia Pacific
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

  • Latin America
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

  • Middle East & Africa
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Non-Invasive Cancer Diagnostics Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Non-Invasive Cancer Diagnostics Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Non-Invasive Cancer Diagnostics Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Non-Invasive Cancer Diagnostics Market product affairs. The report is at risk of project regarding this Non-Invasive Cancer Diagnostics Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Gen-Probe Inc
  • Digene Corporation
  • Quest Diagnostics Inc
  • Cancer
  • Genetics Inc
  • BIOVIEW Inc
  • AVIVA Biosciences Corporation
  • Laboratory Corporation of America Holdings (LabCorp)
  • A&G Pharmaceutical
  • Affymetrix Inc
  • Precision Therapeutics

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Non-Invasive Cancer Diagnostics related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Non-Invasive Cancer Diagnostics Market

Non-Invasive Cancer Diagnostics Market

Report Highlights:


The Non-Invasive Cancer Diagnostics Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Non-Invasive Cancer Diagnostics Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Non-Invasive Cancer Diagnostics Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Non-Invasive Cancer Diagnostics Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Non-Invasive Cancer Diagnostics marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Non-Invasive Cancer Diagnostics market using a bottom-up approach, wherein manufacturers value data for different type (CTCs, CTNAS, Exosomes), of Non-Invasive Cancer Diagnostics market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Non-Invasive Cancer Diagnostics Market

Non-Invasive Cancer Diagnostics Market

Key Target Audience:


  • Non-Invasive Cancer Diagnostics market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Non-Invasive Cancer Diagnostics market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Non-Invasive Cancer Diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Non-Invasive Cancer Diagnostics market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • CTCs
  • CTNAS
  • Exosomes

By end-user also classify into, the Global Non-Invasive Cancer Diagnostics market:


Global Non-Invasive Cancer Diagnostics market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Blood
  • Urine
  • Saliva

Highlights of this 2021-2027 Non-Invasive Cancer Diagnostics Market Report:

  • Market dynamics, Non-Invasive Cancer Diagnostics economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Non-Invasive Cancer Diagnostics industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Non-Invasive Cancer Diagnostics Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Non-Invasive Cancer Diagnostics businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Non-Invasive Cancer Diagnostics market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
Table of Contents

1 Study Coverage
1.1 Non-Invasive Cancer Diagnostics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Product
1.4.2 CTCs
1.4.3 CTNAS
1.4.4 Exosomes
1.5 Market by End User
1.5.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by End User
1.5.2 Blood
1.5.3 Urine
1.5.4 Saliva
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Non-Invasive Cancer Diagnostics Market Size
2.1.1 Global Non-Invasive Cancer Diagnostics Revenue 2016-2027
2.1.2 Global Non-Invasive Cancer Diagnostics Sales 2016-2027
2.2 Non-Invasive Cancer Diagnostics Growth Rate by Regions
2.2.1 Global Non-Invasive Cancer Diagnostics Sales by Regions
2.2.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.2 Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers
3.1.3 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Non-Invasive Cancer Diagnostics Revenue by Manufacturers
3.2.1 Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2016-2021)
3.2.2 Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2016-2021)
3.3 Non-Invasive Cancer Diagnostics Price by Manufacturers
3.4 Non-Invasive Cancer Diagnostics Manufacturing Base Distribution, Product Types
3.4.1 Non-Invasive Cancer Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non-Invasive Cancer Diagnostics Product Type
3.4.3 Date of International Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Non-Invasive Cancer Diagnostics Sales by Product
4.2 Global Non-Invasive Cancer Diagnostics Revenue by Product
4.3 Non-Invasive Cancer Diagnostics Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Non-Invasive Cancer Diagnostics Breakdown Data by End User

6 North America
6.1 North America Non-Invasive Cancer Diagnostics by Countries
6.1.1 North America Non-Invasive Cancer Diagnostics Sales by Countries
6.1.2 North America Non-Invasive Cancer Diagnostics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Non-Invasive Cancer Diagnostics by Product
6.3 North America Non-Invasive Cancer Diagnostics by End User

7 Europe
7.1 Europe Non-Invasive Cancer Diagnostics by Countries
7.1.1 Europe Non-Invasive Cancer Diagnostics Sales by Countries
7.1.2 Europe Non-Invasive Cancer Diagnostics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Non-Invasive Cancer Diagnostics by Product
7.3 Europe Non-Invasive Cancer Diagnostics by End User

8 Asia Pacific
8.1 Asia Pacific Non-Invasive Cancer Diagnostics by Countries
8.1.1 Asia Pacific Non-Invasive Cancer Diagnostics Sales by Countries
8.1.2 Asia Pacific Non-Invasive Cancer Diagnostics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Non-Invasive Cancer Diagnostics by Product
8.3 Asia Pacific Non-Invasive Cancer Diagnostics by End User

9 Central & South America
9.1 Central & South America Non-Invasive Cancer Diagnostics by Countries
9.1.1 Central & South America Non-Invasive Cancer Diagnostics Sales by Countries
9.1.2 Central & South America Non-Invasive Cancer Diagnostics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Non-Invasive Cancer Diagnostics by Product
9.3 Central & South America Non-Invasive Cancer Diagnostics by End User

10 Middle East and Africa
10.1 Middle East and Africa Non-Invasive Cancer Diagnostics by Countries
10.1.1 Middle East and Africa Non-Invasive Cancer Diagnostics Sales by Countries
10.1.2 Middle East and Africa Non-Invasive Cancer Diagnostics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Non-Invasive Cancer Diagnostics by Product
10.3 Middle East and Africa Non-Invasive Cancer Diagnostics by End User

11 Company Profiles
11.1 Gen-Probe Inc
11.1.1 Gen-Probe Inc Company Details
11.1.2 Company Business Overview
11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.1.4 Gen-Probe Inc Non-Invasive Cancer Diagnostics Products Offered
11.1.5 Gen-Probe Inc Recent Development
11.2 Digene Corporation
11.2.1 Digene Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.2.4 Digene Corporation Non-Invasive Cancer Diagnostics Products Offered
11.2.5 Digene Corporation Recent Development
11.3 Quest Diagnostics Inc
11.3.1 Quest Diagnostics Inc Company Details
11.3.2 Company Business Overview
11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.3.4 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Products Offered
11.3.5 Quest Diagnostics Inc Recent Development
11.4 Cancer, Genetics Inc
11.4.1 Cancer, Genetics Inc Company Details
11.4.2 Company Business Overview
11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.4.4 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Products Offered
11.4.5 Cancer, Genetics Inc Recent Development
11.5 BIOVIEW Inc
11.5.1 BIOVIEW Inc Company Details
11.5.2 Company Business Overview
11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.5.4 BIOVIEW Inc Non-Invasive Cancer Diagnostics Products Offered
11.5.5 BIOVIEW Inc Recent Development
11.6 AVIVA Biosciences Corporation
11.6.1 AVIVA Biosciences Corporation Company Details
11.6.2 Company Business Overview
11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.6.4 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Products Offered
11.6.5 AVIVA Biosciences Corporation Recent Development
11.7 Laboratory Corporation of America Holdings (LabCorp)
11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
11.7.2 Company Business Overview
11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.7.4 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Products Offered
11.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
11.8 A&G Pharmaceutical
11.8.1 A&G Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.8.4 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Products Offered
11.8.5 A&G Pharmaceutical Recent Development
11.9 Affymetrix Inc
11.9.1 Affymetrix Inc Company Details
11.9.2 Company Business Overview
11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.9.4 Affymetrix Inc Non-Invasive Cancer Diagnostics Products Offered
11.9.5 Affymetrix Inc Recent Development
11.10 Precision Therapeutics
11.10.1 Precision Therapeutics Company Details
11.10.2 Company Business Overview
11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2016-2021)
11.10.4 Precision Therapeutics Non-Invasive Cancer Diagnostics Products Offered
11.10.5 Precision Therapeutics Recent Development

12 Future Forecast
12.1 Non-Invasive Cancer Diagnostics Market Forecast by Regions
12.1.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2021-2027
12.1.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2021-2027
12.2 Non-Invasive Cancer Diagnostics Market Forecast by Product
12.2.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Product 2021-2027
12.2.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Product 2021-2027
12.3 Non-Invasive Cancer Diagnostics Market Forecast by End User
12.4 North America Non-Invasive Cancer Diagnostics Forecast
12.5 Europe Non-Invasive Cancer Diagnostics Forecast
12.6 Asia Pacific Non-Invasive Cancer Diagnostics Forecast
12.7 Central & South America Non-Invasive Cancer Diagnostics Forecast
12.8 Middle East and Africa Non-Invasive Cancer Diagnostics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non-Invasive Cancer Diagnostics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Non-Invasive Cancer Diagnostics Market Segments


Non-Invasive Cancer Diagnostics Product Type Outlook (Revenue, USD Million, 2021 2027)


  • CTCs
  • CTNAS
  • Exosomes

Non-Invasive Cancer Diagnostics Application Outlook (Revenue, USD Million, 2021 2027)


  • Blood
  • Urine
  • Saliva

Non-Invasive Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

  • Europe
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

  • Asia Pacific
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

  • Latin America
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

  • Middle East & Africa
    • Non-Invasive Cancer Diagnostics market, By Product Type Outlook
      • CTCs
      • CTNAS
      • Exosomes

    • Non-Invasive Cancer Diagnostics market, By Application Outlook
      • Blood
      • Urine
      • Saliva

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Tables and Figures

Figure Non-Invasive Cancer Diagnostics Product Picture
Table Non-Invasive Cancer Diagnostics Market Segments
Table Key Manufacturers Non-Invasive Cancer Diagnostics Covered
Table Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Product 2021-2027 (K Units) & (Million US$)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Product 2016-2027
Figure CTCs Product Picture
Table Major Manufacturers of CTCs
Figure CTNAS Product Picture
Table Major Manufacturers of CTNAS
Figure Exosomes Product Picture
Table Major Manufacturers of Exosomes
Table Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by End User 2021-2027 (K Units)
Figure Blood
Figure Urine
Figure Saliva
Figure Non-Invasive Cancer Diagnostics Report Years Considered
Figure Global Non-Invasive Cancer Diagnostics Market Size 2016-2027 (Million US$)
Figure Global Non-Invasive Cancer Diagnostics Sales 2016-2027 (K Units)
Table Global Non-Invasive Cancer Diagnostics Market Size by Regions 2016-2021 (K Units) & (Million US$)
Table Global Non-Invasive Cancer Diagnostics Sales by Regions 2016-2021 (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions 2016-2021
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions 2016-2021
Figure 2020 Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions
Table Global Non-Invasive Cancer Diagnostics Revenue by Regions 2016-2021 (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions 2016-2021
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions 2016-2021
Figure 2020 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions
Table Global Non-Invasive Cancer Diagnostics Sales by Manufacturers (2016-2021) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by Manufacturers (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Sales Share by Manufacturers in 2020
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2016-2021) (Million USD)
Table Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2016-2021)
Figure Non-Invasive Cancer Diagnostics Value Share by Manufacturers in 2020
Table Key Manufacturers Non-Invasive Cancer Diagnostics Price (2016-2021) (USD/Unit)
Table Non-Invasive Cancer Diagnostics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Non-Invasive Cancer Diagnostics Product Type
Table Date of International Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Non-Invasive Cancer Diagnostics Sales by Product (2016-2021) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by Product (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Product (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Product in 2020
Table Global Non-Invasive Cancer Diagnostics Revenue by Product (2016-2021) (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Share by Product (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Product (2016-2021)
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Product in 2020
Table Non-Invasive Cancer Diagnostics Price by Product 2016-2021 (USD/Unit)
Table Global Non-Invasive Cancer Diagnostics Sales by End User (2016-2021) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by End User (2016-2021)
Figure Global Sales Non-Invasive Cancer Diagnostics Market Share by End User (2016-2021)
Figure Global Sales Non-Invasive Cancer Diagnostics Market Share by End User in 2020
Figure North America Non-Invasive Cancer Diagnostics Sales Growth Rate 2016-2021 (K Units)
Figure North America Non-Invasive Cancer Diagnostics Revenue Growth Rate 2016-2021 (Million US$)
Table North America Non-Invasive Cancer Diagnostics Sales by Countries (2016-2021) (K Units)
Table North America Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2016-2021)
Figure 2020 North America Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table North America Non-Invasive Cancer Diagnostics Revenue by Countries (2016-2021) (Million US$)
Table North America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2016-2021)
Figure 2020 North America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure United States Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure United States Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (K Units)
Figure Canada Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Canada Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Mexico Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Mexico Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Table North America Non-Invasive Cancer Diagnostics Sales by Product (2016-2021) (K Units)
Table North America Non-Invasive Cancer Diagnostics Sales Market Share by Product (2016-2021)
Figure 2020 North America Non-Invasive Cancer Diagnostics Market Share by Product
Table North America Non-Invasive Cancer Diagnostics Sales by End User (2016-2021) (K Units)
Table North America Non-Invasive Cancer Diagnostics Sales Market Share by End User (2016-2021)
Figure 2020 North America Non-Invasive Cancer Diagnostics Market Share by End User
Figure Europe Non-Invasive Cancer Diagnostics Sales Growth Rate 2016-2021 (K Units)
Figure Europe Non-Invasive Cancer Diagnostics Revenue Growth Rate 2016-2021 (Million US$)
Table Europe Non-Invasive Cancer Diagnostics Sales by Countries (2016-2021) (K Units)
Table Europe Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2016-2021)
Figure 2020 Europe Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table Europe Non-Invasive Cancer Diagnostics Revenue by Countries (2016-2021) (Million US$)
Table Europe Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2016-2021)
Figure 2020 Europe Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure Germany Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Germany Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure France Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure France Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure UK Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure UK Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Italy Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Italy Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Russia Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Russia Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Table Europe Non-Invasive Cancer Diagnostics Sales by Product (2016-2021) (K Units)
Table Europe Non-Invasive Cancer Diagnostics Sales Market Share by Product (2016-2021)
Figure 2020 Europe Non-Invasive Cancer Diagnostics Market Share by Product
Table Europe Non-Invasive Cancer Diagnostics Sales by End User (2016-2021) (K Units)
Table Europe Non-Invasive Cancer Diagnostics Sales Market Share by End User (2016-2021)
Figure 2020 Europe Non-Invasive Cancer Diagnostics Market Share by End User
Figure Asia Pacific Non-Invasive Cancer Diagnostics Sales Growth Rate 2016-2021 (K Units)
Figure Asia Pacific Non-Invasive Cancer Diagnostics Revenue Growth Rate 2016-2021 (Million US$)
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales by Countries (2016-2021) (K Units)
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2016-2021)
Figure 2020 Asia Pacific Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table Asia Pacific Non-Invasive Cancer Diagnostics Revenue by Countries (2016-2021) (Million US$)
Table Asia Pacific Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2016-2021)
Figure 2020 Asia Pacific Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure China Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure China Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Japan Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Japan Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Korea Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure Korea Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure India Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Figure India Non-Invasive Cancer Diagnostics Revenue Growth Rate (2016-2021) (Million US$)
Figure Australia Non-Invasive Cancer Diagnostics Sales Growth Rate (2016-2021) (K Units)
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Antibody Drug Conjugates Contract Manufacturing Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Therapeutic Drug Monitoring Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Topical Drug Delivery System Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More